Table of contents

July 2013 - Volume 89 - Suppl 1

STI & AIDS World Congress 2013 July 14-17 Vienna, Austria

Sexually Transmitted Infections: 89 (Suppl 1)

KL - Keynote lecture

PL.01 - Plenary session 1

PL.02 - Plenary session 2

PL.03 - Plenary session 3: Anton Luger Memorial

PL.04 - Plenary session 4

PL.05 - Plenary session 5

S.01 - Microbicides to prevent HIV/STD 2013: An Update

S.02 - Translating and implementing the results of diagnostic assay evaluations: From the research laboratory to patient care

S.03 - Advancing prevention of sexually transmitted infections through sexual health promotion: Opportunities and lessons learned (organised by CDC/WHO/ECDC)

S.04 - Scaling up of HIV treatment programmes among the most at-risk populations in low- and middle-income countries

S.05 - Fostering an Integrated Approach to the Control of Antimicrobial Resistance in Neisseria gonorrhoeae (WHO Symposium)

S.06 - How does your partner know?

S.07 - Bacterial virulence and host response

S.08 - STI/HIV treatment guidelines: Important areas of clinical uncertainty

S.09 - Molecular mechanisms of antimicrobial resistance

S.10 - HIV treatment as prevention

S.12 - STD vaccines and correlates of immunity

S.13 - Challenges to a comprehensive approach to the prevention of HIV and STI among men who have sex with men in Europe (organised by ECDC)

S.14 - New strategies and implementation of best practises for dual elimination of mother-to-child transmission of syphilis and HIV (organised by WHO)

S.15 - Sexual networks and contagion (Insights from phylodynamic studies, behaviour diffusion, social media studies)

S.16 - Challenging clinical conditions

YI - American Sexually Transmitted Diseases Association – Young Investigators Symposium: research in progress: Highlights from the American STD association developmental awards programme

O.01 - Microbial virulence and host response

O.02 - Antimicrobial therapy for genital tract infections

O.03 - Neisseria gonorrhoeae resistance: Superbug ante portas?

O.04 - Vaginal infections and PID

O.05 - Molecular analysis of STI pathogens and their environments

O.06 - Clinical issues and potential solutions

O.07 - Sexually transmitted infections: social and behavioural determinants and consequences

O.08 - Get those partners treated!

O.09 - Programme implementation and scaling up

O.10 – HPV: genital tract malignancy and vaccination

O.11 - HIV prevention and lessons learned from trials of HIV pre-exposure prophylaxis

O.13 - Epidemic appraisal and strategic planning

O.14 - Clinical syndromes

O.15 - For lab rats and other mice and men

O.16 - STI-Potpourri: Chlamydia, HPV and special populations

O.17 - Programme evaluation

O.18 - Diagnosis of sexually transmitted infections

O.19 - Prevention and curing STIs: Who is the winner?

O.20 - Sexual partnerships and networks

O.21 - Antimicrobial resistance mechanisms in STI pathogens

O.22 - Alternative screening tools and screening sites

O.23 - Risk behaviours and preventive interventions

P.01 - Basic Sciences Track

P.02 - Clinical Sciences Track

P.03 - Epidemiology and Prevention Sciences Track

P.05 - Translational and Implementation Sciences Track

P.06 - Health Policy and Programme Sciences Track